Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Beyond Air, Inc.
Beyond Air, Inc. filed a Schedule 13G/A, reporting the beneficial ownership status of Lin Yi-Chien. This filing reflects an update or amendment to the previously reported equity holdings in the company.…more
Beyond Air, Inc.
Beyond Air, Inc. will hold its annual meeting of stockholders on December 10, 2026, to vote on matters including the election of directors, ratification of the independent auditor, and executive compensation. The company has changed its fiscal year-end from March 31 to December 31, establishing a transition period from April 1, 2026, to December 31, 2026. As of the record date of October 12, 2026, there are 1,665,482 shares of common stock outstanding.…more
Beyond Air, Inc.
Insider Lin Yi-Chien of Beyond Air, Inc. filed a Form 4 on October 13, 2026, reporting changes in beneficial ownership of securities. This filing serves as the official disclosure regarding the equity position changes of the reporting individual.…more
15 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Beyond Air Affirms FY2027 Sales Guidance
Beyond Air has reaffirmed its fiscal year 2027 sales outlook, projecting revenue between $16 million and $18 million. This guidance aligns closely with the market consensus estimate of $16.715 million.…more
●●●●●●●● ●●●●● ●●●●●●
Beyond Air announced preliminary third-quarter revenue of $2.3 million, marking a 30% sequential increase. The company reaffirmed its full-year revenue guidance, citing continued adoption of its LungFit PH system.…more
●●●●●●●● ●●●●● ●●●●●●
Beyond Air has published a new patent application for methods using gaseous nitric oxide to inhibit tumor growth. This development highlights the company's ongoing research efforts in potential cancer treatment applications.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.